Sort
39,280 grants matching “leukemia”
Developmental and HyperActive Ras Tumor SPORE
$2,102,055David W. Clapp · Indiana University Indianapolis · U54 · FY2018 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$2,101,526John E Wagner · University Of Minnesota · P01 · FY2023 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2020 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2021 · CA
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$2,099,686Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2014 · HG
Studies of Populations Exposed to Occupational Sources of Radiation
$2,099,548Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2016 · CA
Immunogenetics of Graft-Versus-Host Disease
$2,098,949Effie W Petersdorf · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA
Hematopoietic Stem Cells for Transplantation
$2,096,756Saul J Sharkis · Johns Hopkins University · P01 · FY2009 · CA
Development of New Antitumor Agents
$2,095,999Southern Research Institute · P01 · FY2002 · CA
Environmental and Molecular Epidemiology of Childhood Leukemia
$2,095,821Patricia A Buffler · University Of California Berkeley · R01 · FY2011 · ES
NGTC - UCL
$2,095,142Martin Pule · University College London · OT2 · FY2022 · CA
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$2,094,748Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2024 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$2,093,238Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Washington University SPORE in Pancreatic Cancer
$2,091,214David G Denardo · Washington University · P50 · FY2024 · CA
Developmental Therapeutics Program
$2,090,969Richard D Schulick · University Of Colorado Denver · P30 · FY2024 · CA
Developmental Therapeutics Program
$2,090,964Richard D Schulick · University Of Colorado Denver · P30 · FY2023 · CA
Expansion of antigen-specific T cells using programmable biomaterials for adoptive cellular therapy
$2,090,715Catherine Ju-Ying Wu · Harvard University · U54 · FY2019 · CA
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
$2,089,499Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2013 · CA
Alliance for Clinical Trials in Oncology Operations Center
$2,088,480Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2017 · CA
THERAPY OF CML
$2,088,460University Of Texas Md Anderson Can Ctr · P01 · FY2003 · CA
Impacts of Genetic and Environmental Factors on Reproductive Organ Development
$2,088,356Hung Chang Yao · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Topology of Cancer Evolution and Heterogeneity
$2,087,754Raul Rabadan · Columbia University Health Sciences · U54 · FY2017 · CA
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
$2,087,361Lisa Rimsza · Mayo Clinic Arizona · P01 · FY2018 · CA